
You asked: Can we monitor the usage of biosimilars in secondary care using OpenPrescribing Hospitals?
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?
This is a beta version of OpenPrescribing Hospitals for testing and feedback purposes. Data and functionality may be incomplete. Please contact us if you find any issues or have feedback.
Explore, analyse and compare hospital medicines data from NHS Trusts across England
View the data submission history for each NHS Trust in England over time and identify gaps in reporting.
View HistoryExplore a curated set of measures that highlight variation in medicines issued across NHS Trusts.
View MeasuresBuild your own analysis. Explore trends for individual products or groups of related products issued across NHS Trusts.
Start AnalysingOur latest blog posts and research papers
What are biosimilars, why are they of interest and why can we monitor usage with primary care data but not secondary care data?
A look at the new Product Lookup feature on OpenPrescribing Hospitals
What is a Defined Daily Dose, how can they calculated from the quantity reported in the Secondary Care Medicines Data, and why are they useful?
Under Development
OpenPrescribing Hospitals is currently under development and conducting user testing. If you are interested in accessing the platform, please contact us.
Follow our blog for updates on our progress or sign up to our newsletter.